AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05901883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CEL383
Description: Subjects will receive CEL383
Study NCT05901883 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive placebo
Study NCT06328933 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric Tube Feeding
Description: The control group was given enteral nutritional support with Nasogastric Tube Feeding according to the relevant guidelines. Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient\&#39;s cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. The feeding content was formulated by the nutritionists based on the patients condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups. For patients with limited tube feeding compliance, we made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
Study NCT06328933 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The observation group was given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm. However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly. After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation. Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Study NCT06328933 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: comprehensive rehabilitation therapy
Description: Including： Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.~Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT06328933 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: comprehensive rehabilitation therapy
Description: Including： Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.~Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT05090813 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Model ICB00
Description: Investigational intraocular lens replaces the natural lens removed during cataract surgery in one or both eyes.
Study NCT05539378 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auditory Stimulation
Description: enhancement of sleep slow wave activity through acoustic stimulation
Study NCT05539378 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham (no stimulation)
Description: Playing no tones during sleep but still recording brain activity
Study NCT06265506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management
Description: Contingency Management (CM) is an intervention that uses positive reinforcement (e.g. gift cards) to reinforce a desired behavior (e.g. negative alcohol biomarker tests) on a frequent (e.g. weekly), escalating (e.g. $5/week) schedule (e.g. 26 weeks) in order to increase the occurrence of that behavior (e.g. long term alcohol abstinence or reduction in drinking).
Study NCT06265506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT)
Description: CBT4CBT is an evidence-based online intervention that teaches CBT principles and skills to help people with alcohol use disorder reduce their drinking. CBT4CBT teaches CBT principles through video, graphics, audio instruction, and interactive exercises. Modules include video-based examples to emphasize learning of behavioral, cognitive, and affective strategies, with an emphasis on learning from examples of individuals using skills in a range of situations. Skills taught include functional analysis, coping with craving and emotions, problem solving, decision making, challenging thoughts, and assertive alcohol refusal. Interactive exercises and homework are used to encourage skills learning and practice.
Study NCT06265506 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Computer Based Training for Cognitive Behavioral Therapy for AUD (CBT4CBT)
Description: CBT4CBT is an evidence-based online intervention that teaches CBT principles and skills to help people with alcohol use disorder reduce their drinking. CBT4CBT teaches CBT principles through video, graphics, audio instruction, and interactive exercises. Modules include video-based examples to emphasize learning of behavioral, cognitive, and affective strategies, with an emphasis on learning from examples of individuals using skills in a range of situations. Skills taught include functional analysis, coping with craving and emotions, problem solving, decision making, challenging thoughts, and assertive alcohol refusal. Interactive exercises and homework are used to encourage skills learning and practice.
Study NCT05485337 — intervention group
Intervention type: OTHER
Intervention: visual analog scale
Description: Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.
Study NCT06206915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZ120 injection
Description: in Part One：XZ120 monotherapy, IV, no less than 60min, Q3W dose escalation study: 4 dose group (0.75 mg/m2, 1.5 mg/m2, 2.25 mg/m2, 3.0 mg/m2) Dose expansion study: MTD dose
Study NCT05611281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication
Description: The dosage was calculated according to body weight and dose group once a day according to the assigned group.
Study NCT05611281 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GS3-007 oral liquid or Placebo GS3-007 oral liquid oral medication
Description: The dosage was calculated according to body weight and dose group once a day according to the assigned group.
Study NCT04781127 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Soterix Medical mini-CT tDCS stimulator
Description: Stimulation will last 30 minutes per day, 5 days per week, for 5 weeks, then 3 days per week for 1 week and then 1 day per week for 4 weeks.
Study NCT05011240 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Paediatric Autism Communication Therapy (PACT)
Description: PACT is a parent-mediated therapy that aims to improve children's social-communication development. During PACT, a therapist uses video-feedback of parent-child play interactions to coach the parent in how to improve their sensitivity and responsiveness to their child's social-communication and interaction behaviours and to implement evidence-based strategies that facilitate social-communication development.
Study NCT05011240 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Control participants will receive monthly psychoeducation sessions led by a developmental specialist
Study NCT05798559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Training
Description: These are the trainings given by the researchers in order to regulate the sleep routine and environment. Content will be presented to improve sleep processes by arranging living habits.
Study NCT05107557 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Experimental Group
Description: The COVID-19 vaccine was manufactured by Sinovac Research \& Development Co., Ltd, and the EV71 vaccine was manufactured by Sinovac Biotech Co.The COVID-19 vaccine:600SU inactivated virus in 0.5mL of aluminium hydroxide solution per injection;The EV71 vaccine:Inactivated EV71 virus antigen no less than 3.0EU in 0.5 mL of aluminium hydroxide solution per injection.
Study NCT05107557 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: The COVID-19 vaccine was manufactured by Sinovac Research \& Development Co., Ltd, and the EV71 vaccine was manufactured by Sinovac Biotech Co.The COVID-19 vaccine:600SU inactivated virus in 0.5mL of aluminium hydroxide solution per injection;The EV71 vaccine:Inactivated EV71 virus antigen no less than 3.0EU in 0.5 mL of aluminium hydroxide solution per injection.
Study NCT05597852 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpaceOAR
Description: SpaceOAR hydrogel spacer between the prostate and rectum, in an effort to decrease toxicity and improve patient's bowel quality of life.
Study NCT06158087 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pEGASUS Stent System
Description: Endovascular intervention with p64/p48 MW HPC pEGASUS Stent System was performed in patients diagnosed with intracranial aneurysms
Study NCT05066880 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Exercise training for 8 weeks
Study NCT05933044 — intervention group
Intervention type: DRUG
Intervention: Durvalumab
Description: Chemoradiotherapy plus durvalumab
Study NCT05506670 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diagnostic test and phone call
Description: Viral diagnostic test will be performed at inclusion. In case of RSV positive results, follow up phone calls will be scheduled at day 14 and day 30 to collect data.
Study NCT05506670 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diagnostic test
Description: Viral diagnostic test will be performed at inclusion. In case of RSV negative result, no more intervention will be required.
Study NCT04599075 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: IV Insulin Infusion
Study NCT04599075 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: Continuous Subcutaneous Insulin Infusion (Pump)
Study NCT05629819 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive phrenic nerve stimulation
Description: Some studies have shown that PNS can relieve diaphragmatic atrophy and reverse diaphragmatic dysfunction.
Study NCT06515119 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resources-Oriented Salutogenic (ROS) intervention
Description: Participants in intervention group will receive an online ROS course via Zoom meeting, post daily salutogenic recordings and comments on Facebook. A closed Facebook group will be created to deliver resources booklet, zoom meeting links, as well as encourage participants share their daily salutogenic recording, give comments and thumps-up by group members.
Study NCT06405594 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Language Condition
Description: The intervention involves asking participants to speak and understand words and sentences with different linguistic manipulations such as morphological, semantic, phonological priming, predictability of the subject and object nouns associated with verbs, naming of verbs and nouns, production of sentences with past, future or present tense. Accuracy, response times and brain activity are the outcome measures.
Study NCT06105528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PMN310
Description: 60-minute intravenous infusion
Study NCT06105528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 60-minute intravenous infusion
Study NCT04612907 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Moderate hypo-fractionation
Description: Patients will receive four weeks of radiotherapy
Study NCT04612907 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra-hypo-fractionation
Description: Patients will receive two and a half weeks of radiotherapy
Study NCT05310071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aducanumab
Description: Administered as specified in the treatment arm.
Study NCT05310071 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.
Study NCT06468241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercise
Description: For the progressive relaxation exercise group, a progressive relaxation exercise session will be applied to the participants 3 times a week for four weeks.
Study NCT06468241 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Listening to music
Description: For the music listening group, the participants will listen to the Turkish music makams (uşşak and rast) three times a week for four weeks.
Study NCT05389176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmolol
Description: a continuous esmolol infusion titrated to maintain heart rate between 70/min and 100/min
Study NCT06443983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI-supported case
Description: In the artificial intelligence-supported case lesson, students will listen to audio and visual content prepared by artificial intelligence.
Study NCT06299644 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Sleeve Gastroplasty - Belt and Suspenders
Description: Endoscopic sleeve gastroplasty using belt and suspender plications.
Study NCT06299644 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Sleeve Gastroplasty - Belt
Description: Endoscopic sleeve gastroplasty using belt only plications.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: All Natural descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gluten-free descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vegan descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 100% Organic descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Handcrafted descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Made with live resin descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fast-acting descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT06171399 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relax descriptor
Description: Participants in the nine intervention conditions will be shown four cannabis edibles packages that have been altered to contain one of the product descriptors of interest. All participants will see the same four products, and each condition will see the products with the same descriptor.
Study NCT05475236 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Experimental: Locomotor Learning
Description: Participants will undergo four sessions of locomotor and turn learning. Locomotor learning will involve practicing walking over different terrains (i.e., soft and firm mats) and obstacles at different walking speeds (slow or fast) and turning practice at each end of the walking course. The full cohort will undergo either transcranial direct current stimulation or sham stimulation.
Study NCT05475236 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Locomotor Learning
Description: Participants will undergo four sessions of locomotor and turn learning. Locomotor learning will involve practicing walking over different terrains (i.e., soft and firm mats) and obstacles at different walking speeds (slow or fast) and turning practice at each end of the walking course. The full cohort will undergo either transcranial direct current stimulation or sham stimulation.
Study NCT05544838 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LMA insertion with standard technique
Description: Standard LMA insertion technique; LMA held like a pen and index finger placed at the junction of LMA tube and cuff. Index finger used to press LMA against hard palate and posterior pharyngeal wall until definite resistance felt at the base of hypopharynx. LMA then held with non- dominant hand and index finger removed.~Rotational LMA insertion; LMA inserted like guedel airway insertion: LMA proximally grasped close to anaesthesia circuit attachment. Insertion was conducted with LMA cuff facing towards nose, hard palate and then advanced into the base of hypopharynx until resistance was felt. At this point, LMA rotated at 180 degree anti-clockwise and LMA tube black line positioned and confirmed on the nasal side.
Study NCT04903405 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention is involved in this study
Study NCT05129878 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scaling and OHI
Description: patients with PCOS on combined oral contraceptives (COCs) having gingivitis will receive scaling and oral hygiene instructions
Study NCT05129878 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: oral Hygiene instructions
Description: patients with PCOS on combined oral contraceptives (COCs) having gingivitis will receive oral hygiene instructions only
Study NCT05129878 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and oral hygiene instruction
Description: Systemically Healthy (age and BMI matched) females with gingivitis will receive with OHI and Scaling
Study NCT06072937 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IntelliStent
Description: Staged implantation of IntelliStent. The system comprises a nitinol self-expanding stent with a hollow element delivered over-the-wire into the main pulmonary artery or its left and right branches, using an 18 Fr transfemoral introducer sheath. The stent consists of two sections, one with a larger diameter and one with a smaller diameter, available in 6 sizes suitable for vessel sizes ranging from 20mm to 30 mm. Additional smaller sizes are currently under development.
Study NCT06197035 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coping With and Caring for Infants With Special Needs
Description: The early intervention programme for infants and young children focuses on the active inclusion of the whole family. The coaching of parents is a central component. Parents learn how they can independently and optimally support their child's development as part of the child's everyday life. The programme was developed at the beginning of the 2000s in the Netherlands by child physiotherapist Tineke Dirks and professor of developmental neurology Mijna Hadders-Algra.
Study NCT06313567 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronomic capecitabine group
Description: 500 mg/m2 body surface area twice daily for 1 year; metronomic capecitabine group
Study NCT06313567 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Observation
Description: observation
Study NCT04752111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esmolol
Description: administration of a loading dose esmolol infusion 0.5 mg/kg in 30 ml isotonic saline in the IV line, followed by an IV infusion of esmolol 0.05 mg/kg/min till the completion of surgery
Study NCT04752111 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Esmolol
Description: administration of a loading dose esmolol infusion 0.5 mg/kg in 30 ml isotonic saline in the IV line, followed by an IV infusion of esmolol 0.05 mg/kg/min till the completion of surgery